Inclusion of Potentially Inappropriate Medicines for the Older Adults in the Brazilian Consensus in Accordance with International Criteria.
Andrea Pecce BentoLeonardo Costa PereiraKerolyn Ramos GarciaLuiz Fernando Ramos FerreiraEmília Vitória da SilvaMargô KarnikowskiPublished in: Clinical interventions in aging (2022)
The results suggest the need for periodic validation of PIM against research clinics, new drugs and the inclusion of this agenda by the Ministry of Health in the revision of the National List of Essential Drugs and other Clinical Protocols and Therapeutic Prescription Guidelines for the older adults.